Mark Richard Ashton

Person

Abington, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Spiroindolinepiperidine derivatives
- Patent number 9,686,990
- Issue date Jun 27, 2017
- Syngenta Participations AG
- David John Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiroindolinepiperidine derivatives
- Patent number 9,174,987
- Issue date Nov 3, 2015
- Syngenta Limited
- David John Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,314,257
- Issue date Nov 20, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,198,314
- Issue date Jun 12, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,936
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,931
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EP2 receptor agonists
- Patent number 8,080,567
- Issue date Dec 20, 2011
- Asterand UK Limited
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EP2 receptor agonists
- Patent number 7,803,841
- Issue date Sep 28, 2010
- Asterand UK Limited
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EP2 receptor agonists
- Patent number 7,662,839
- Issue date Feb 16, 2010
- Asterand UK Limited
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of CRTH2-mediated diseases and conditions
- Patent number 7,582,672
- Issue date Sep 1, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EP2 receptor agonists
- Patent number 7,326,732
- Issue date Feb 5, 2008
- Pharmagene Laboratories Limited
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SPIROINDOLINEPIPERIDINE DERIVATIVES
- Publication number 20160007608
- Publication date Jan 14, 2016
- SYNGENTA LIMITED
- David John Hughes
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
SPIROINDOLINEPIPERIDINE DERIVATIVES
- Publication number 20120010220
- Publication date Jan 12, 2012
- Syngenta Crop Protection LLC
- David John Hughes
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
EP2 Receptor Agonists
- Publication number 20100261760
- Publication date Oct 14, 2010
- Asterand UK Limited
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EP2 RECEPTOR AGONISTS
- Publication number 20100130556
- Publication date May 27, 2010
- ASTERAND UK LIMITED
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EP2 RECEPTOR AGONISTS
- Publication number 20090298899
- Publication date Dec 3, 2009
- Asterand UK Limited
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090023788
- Publication date Jan 22, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018138
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018139
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-Mediated diseases and conditions
- Publication number 20090018338
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrazine Derivatives As Effective Compounds Against Infectious Dise...
- Publication number 20080194574
- Publication date Aug 14, 2008
- AXXIMA PHARMACEUTICALS AG
- Jan Eike Eikhoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EP2 RECEPTOR AGONISTS
- Publication number 20080119526
- Publication date May 22, 2008
- PHARMAGENE LABORATORIES LIMITED
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having Crth2 Antagonist Activity
- Publication number 20070232681
- Publication date Oct 4, 2007
- Oxagen Limited
- David Middlemiss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glyoxalase inhibitors
- Publication number 20070015799
- Publication date Jan 18, 2007
- Mark Ashton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel betulin derivatives, preparation thereof and use thereof
- Publication number 20060205697
- Publication date Sep 14, 2006
- Gary N. Robinson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Spiroindolinepiperidine derivatives
- Publication number 20060106045
- Publication date May 18, 2006
- David John Hughes
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
EP2 receptor agonists
- Publication number 20050256170
- Publication date Nov 17, 2005
- Alexander William Oxford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel triterpene derivatives, preparation thereof and use thereof
- Publication number 20050148561
- Publication date Jul 7, 2005
- Panacos Pharmaceuticals, Inc.
- Carl T. Wild
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20050119268
- Publication date Jun 2, 2005
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark Richard Ashton

Person

Patents Grantslast 30 patents

Spiroindolinepiperidine derivatives

Spiroindolinepiperidine derivatives

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

EP2 receptor agonists

EP2 receptor agonists

EP2 receptor agonists

Compounds for the treatment of CRTH2-mediated diseases and conditions

EP2 receptor agonists

Patents Applicationslast 30 patents

SPIROINDOLINEPIPERIDINE DERIVATIVES

SPIROINDOLINEPIPERIDINE DERIVATIVES

EP2 Receptor Agonists

EP2 RECEPTOR AGONISTS

EP2 RECEPTOR AGONISTS

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-Mediated diseases and conditions

Pyrazine Derivatives As Effective Compounds Against Infectious Dise...

EP2 RECEPTOR AGONISTS

Compounds Having Crth2 Antagonist Activity

Glyoxalase inhibitors

Novel betulin derivatives, preparation thereof and use thereof

Spiroindolinepiperidine derivatives

EP2 receptor agonists

Novel triterpene derivatives, preparation thereof and use thereof

Treatment of CRTH2-mediated diseases and conditions